{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:18:20Z","timestamp":1791271100821,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>It has been reported in an open-label study that the combination of alkalinized lidocaine and heparin can immediately relieve the symptoms of urinary urgency, frequency, and pain associated with interstitial cystitis (IC). This combination has also been reported to relieve pain associated with sex in patients with IC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The aim of this study was to corroborate these findings in a multicenter setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study design was a multicenter prospective, double-blind, crossover, placebo-controlled trial. Each participant met all of the clinical National Institute of Diabetes and Digestive and Kidney Diseases criteria (excluding cystoscopy) for IC. Each patient received drug and control, in random order, within 48 hours of enrolling in the study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>The primary outcome measure was percent change in pain score (11-point analog pain scale) 12 hours after receiving the drug or control. Secondary measures were the global assessment response (GAR) of symptoms and 12-hour average urgency reduction determined from 11-point urgency scales.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eighteen (18) patients completed the trial. The average reduction of pain over 12 hours was 21% for control and 42% for active drug (P = 0.0363). GAR was 13% for control and 50% for drug (P = 0.0137). Average urgency reduction was 13% for control and 35% for drug (P = 0.0328).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The combination of alkalinized lidocaine and heparin provides up to 12 hours of relief from urgency and pain associated with IC. This combination provides significant immediate relief of symptoms for patients with IC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02542.x","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T15:54:18Z","timestamp":1321286058000},"page":"207-212","source":"Crossref","is-referenced-by-count":55,"title":["Alkalinized Lidocaine and Heparin Provide Immediate Relief of Pain and Urgency in Patients with Interstitial Cystitis"],"prefix":"10.1093","volume":"9","author":[{"given":"C. Lowell","family":"Parsons","sequence":"first","affiliation":[{"name":"Division of Urology, University of California San Diego , San Diego, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zupkas","sequence":"additional","affiliation":[{"name":"Division of Urology, University of California San Diego , San Diego, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Proctor","sequence":"additional","affiliation":[{"name":"Georgia Urology , Cartersville, GA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Koziol","sequence":"additional","affiliation":[{"name":"Scripps Clinic and Research Foundation , La Jolla, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie","family":"Franklin","sequence":"additional","affiliation":[{"name":"Urigen Pharmaceuticals , Walnut Creek, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Giesing","sequence":"additional","affiliation":[{"name":"Urigen Pharmaceuticals , Walnut Creek, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Davis","sequence":"additional","affiliation":[{"name":"Citrus Valley Urologic Medical Group , Glendora, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Lakin","sequence":"additional","affiliation":[{"name":"Division of Urology, University of California San Diego , San Diego, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Kahn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Scripps Clinic and Research Foundation , La Jolla, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Garner","sequence":"additional","affiliation":[{"name":"Urigen Pharmaceuticals , Walnut Creek, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"key":"2024032600262025100_bb0010","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.urology.2006.03.084","article-title":"The role of the urinary epithelium in the pathogenesis of interstitial cystitis\/prostatitis\/urethritis","volume":"69","author":"Parsons","year":"2007","journal-title":"Urology"},{"key":"2024032600262025100_bb0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1464-410X.2010.09843.x","article-title":"The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis\/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain","volume":"107","author":"Parsons","year":"2011","journal-title":"BJU Int"},{"key":"2024032600262025100_bb0020","first-page":"493","article-title":"Bladder surface glycosaminoglycans is a human epithelial permeability barrier","volume":"171","author":"Lilly","year":"1990","journal-title":"Surg Gynecol Obstet"},{"key":"2024032600262025100_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-5347(17)39897-X","article-title":"Bladder surface glycosaminoglycans: An epithelial permeability barrier","volume":"143","author":"Parsons","year":"1990","journal-title":"J Urol"},{"key":"2024032600262025100_bb0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0022-5347(17)38437-9","article-title":"Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis)","volume":"145","author":"Parsons","year":"1991","journal-title":"J Urol"},{"key":"2024032600262025100_bb0035","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/S0022-5347(01)63178-1","article-title":"The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis","volume":"159","author":"Parsons","year":"1998","journal-title":"J Urol"},{"key":"2024032600262025100_bb0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/nau.1930130503","article-title":"Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis","volume":"13","author":"Parsons","year":"1994","journal-title":"Neurourol Urodyn"},{"key":"2024032600262025100_bb0045","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/01.ju.0000148361.82074.77","article-title":"Abnormal urinary potassium metabolism in patients with interstitial cystitis","volume":"173","author":"Parsons","year":"2005","journal-title":"J Urol"},{"key":"2024032600262025100_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urology.2007.09.067","article-title":"Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin","volume":"71","author":"Welk","year":"2008","journal-title":"Urology"},{"key":"2024032600262025100_bb0055","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1743-6109.2011.02251.x","article-title":"Interstitial cystitis is associated with vulvodynia and sexual dysfunction\u2014a case-control study","volume":"8","author":"Gardella","year":"2011","journal-title":"J Sex Med"},{"key":"2024032600262025100_bb0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1743-6109.2009.01631.x","article-title":"Women\u2019s sexual pain disorders","volume":"7","author":"van Lankveld","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600262025100_bb0065","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00192-008-0572-4","article-title":"A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome\/interstitial cystitis","volume":"19","author":"Cervigni","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"2024032600262025100_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.juro.2007.08.170","article-title":"Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: A randomized double-blind clinical trial","volume":"179","author":"Davis","year":"2008","journal-title":"J Urol"},{"key":"2024032600262025100_bb0075","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.juro.2009.07.013","article-title":"Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate","volume":"182","author":"Hauser","year":"2009","journal-title":"J Urol"},{"key":"2024032600262025100_bb0080","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.eururo.2007.03.020","article-title":"Hyaluronic acid: An effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis?","volume":"51","author":"Iavazzo","year":"2007","journal-title":"Eur Urol"},{"key":"2024032600262025100_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2490-5-4","article-title":"Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder","volume":"5","author":"Kyker","year":"2005","journal-title":"BMC Urol"},{"key":"2024032600262025100_bb0090","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.urology.2010.03.016","article-title":"A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis\/painful bladder syndrome","volume":"76","author":"Nickel","year":"2010","journal-title":"Urology"},{"key":"2024032600262025100_bb0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1464-410X.2008.08162.x","article-title":"Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome","volume":"103","author":"Nickel","year":"2009","journal-title":"BJU Int"},{"key":"2024032600262025100_bb0100","first-page":"328","article-title":"Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial","volume":"58","author":"Nordling","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"2024032600262025100_bb0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","article-title":"Treatment of interstitial cystitis with intravesical heparin","volume":"73","author":"Parsons","year":"1994","journal-title":"Br J Urol"},{"key":"2024032600262025100_bb0110","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/S0022-5347(05)66238-6","article-title":"Absorption of alkalized intravesical lidocaine in normal and inflamed bladders: A simple method for improving bladder anesthesia","volume":"165","author":"Henry","year":"2001","journal-title":"J Urol"},{"key":"2024032600262025100_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urology.2004.08.056","article-title":"Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis","volume":"65","author":"Parsons","year":"2005","journal-title":"Urology"},{"key":"2024032600262025100_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-5347(17)41529-1","article-title":"Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28\u201329, 1987","volume":"140","author":"Gillenwater","year":"1988","journal-title":"J Urol"},{"key":"2024032600262025100_bb0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0090-4295(02)01829-0","article-title":"Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity","volume":"60","author":"Parsons","year":"2002","journal-title":"Urology"},{"key":"2024032600262025100_bb0130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-5347(17)35629-X","article-title":"A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate","volume":"150","author":"Parsons","year":"1993","journal-title":"J Urol"},{"key":"2024032600262025100_bb0135","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/01.ju.0000154631.92150.ef","article-title":"Intravesical resiniferatoxin for the treatment of interstitial cystitis: A randomized, double-blind, placebo controlled trial","volume":"173","author":"Payne","year":"2005","journal-title":"J Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/207\/47769748\/jsm_9_1_207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/207\/47769748\/jsm_9_1_207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:19:54Z","timestamp":1711415994000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/1\/207\/6886675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02542.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,1]]},"published":{"date-parts":[[2012,1,1]]}}}